Le Lézard
Classified in: Health
Subjects: NPT, PER, PET, ANW

Schwarzman Animal Medical Center Appoints Helen Irving, RN, MBA, President and Chief Executive Officer


The Seasoned Healthcare Executive Brings 30+ Years of Clinical, Administrative, and Operations Experience

NEW YORK, Jan. 25, 2023 /PRNewswire/ -- The Stephen & Christine Schwarzman Animal Medical Center Board of Trustees has announced Helen Irving, RN, MBA, as its incoming President and Chief Executive Officer. Ms. Irving joins AMC, the largest non-profit animal hospital in the world, on January 30, 2023, during a pivotal time for the 113-year-old Upper East Side institution. The hospital is currently undergoing a $100 Million expansion and modernization project to accommodate unprecedented demand for its veterinary care. 

An accomplished leader and healthcare executive, Helen Irving has devoted her 30-year career to operational excellence in the delivery of healthcare services. As a trained RN with an MBA and over a decade as a healthcare CEO, her wealth of experience and expertise includes hospital operations, clinical care and management, and leadership in healthcare administration.

"Helen is an inspiring leader with deep clinical experience and a proven track record," said Robert Liberman, Chairman of AMC's Board of Trustees. "We are confident she will chart a successful course with the opportunities that lie ahead, ensuring AMC remains at the forefront of excellence and ingenuity."

Prior to joining AMC, Helen served for ten years as President and CEO of LiveOnNY, a federally designated organ procurement non-profit organization serving the New York metropolitan area, and one of the largest organ procurement organizations in the country.

Prior to joining LiveOnNY, Ms. Irving served as Vice President of Hospital Operations at Mount Sinai Medical Center for five years, where she oversaw a broad range of hospital services. She also has held positions as Transplant Operations Manager at New York-Presbyterian Hospital and Clinical Manager at New York Organ Donor Network. She maintains her nursing license after earlier staff nurse positions at hospitals in the United States, Canada, and the United Kingdom.

Ms. Irving holds an MBA in Healthcare Administration from Fairleigh Dickinson University and serves on the boards of the New York State Hemophilia Consortium, the Medical Advisory Board for NYIT, and until recently, the National Cancer Center.

"Leading the Schwarzman Animal Medical Center is such an exciting opportunity given my deep roots in New York's healthcare system," said Ms. Irving. "I am honored to have the opportunity to work with AMC's world class clinical team in serving the region's families and their beloved pets and look forward to getting to know everyone in the AMC family, whose dedication to the best veterinary care possible is truly an inspiration."

"I am so pleased to leave AMC in such wonderful hands," said Kathryn Coyne, who will retire after a 12-year tenure as AMC's President and CEO and will join AMC's Board of Trustees. "I will do everything possible to ensure this transition is a success, and I look forward to continuing to serve AMC on the Board."

Ms. Irving is a native of London but has called New York home for over 30 years. She is a passionate animal lover with a Welsh terrier and a rescue tabby included in her family.

About the Stephen & Christine Schwarzman Animal Medical Center
The Stephen & Christine Schwarzman Animal Medical Center is the world's largest non-profit animal hospital, with 130+ veterinarians providing the highest quality medical care across more than 20 specialties and services, 24 hours a day, 7 days a week. Our mission to provide the best in care, research, and education has been the foundation of our work for over a century. Learn more at: www.amcny.org.

CONTACT: Barbara Ross, [email protected], 845-659-9810

SOURCE Schwarzman Animal Medical Center


These press releases may also interest you

at 02:27
Market Overview The Global Biometric Technologies Market is expected to grow at a compound annual growth rate (CAGR) of around 12% between 2024 and 2031, from an estimated USD 38 billion in 2023 to approximately USD 120 billion by 2031. Our study...

at 02:05
Locate Bio, a pioneering orthobiologics company, today announces the successful completion of an oversubscribed £9.2 million funding round from both new investors and existing investors, Mercia Ventures and BGF. The proceeds will fund a clinical...

at 02:05
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...

at 01:00
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion Respironics litigation settlement reached in the US...

at 00:45
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of ?15 million in its second closing with participation from...

at 00:20
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI...



News published on and distributed by: